Finance

Beta
Lists
KINO:IDX
Kino Indonesia Tbk PT
IDR 1,110.00
+2.78%
(+30.00) 1D
Jun 4, 4:09:16 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KINO...
Open
IDR 1,120
High
IDR 1,120
Low
IDR 1,060
Mkt. cap
1.59T
Avg. vol.
26.58K
Volume
44.70K
Dividend
4.05%
Quarterly dividend
IDR 11
Ex-dividend date
Jun 4, 2026
P/E ratio
10.34
52-wk high
IDR 1,470
52-wk low
IDR 1,010
EPS
IDR 107
Shares outstanding
1.43B
No. of employees
4K
Open
IDR 1,120
High
IDR 1,120
Low
IDR 1,060
Mkt. cap
1.59T
Avg. vol.
26.58K
Volume
44.70K
Dividend
4.05%
Quarterly dividend
IDR 11
Ex-dividend date
Jun 4, 2026
P/E ratio
10.34
52-wk high
IDR 1,470
52-wk low
IDR 1,010
EPS
IDR 107
Shares outstanding
1.43B
No. of employees
4K
News stories
From sources across the web
Profile
PT Kino Indonesia Tbk, formerly PT Kinocare Era Kosmetindo, or simply known as Kino, is an Indonesian multinational consumer goods company headquartered in Tangerang, Banten, founded in 1999 by Harry Sanusi. It specializes the manufacturing of its products in the wide range of personal care, hygiene, health care, confectionery, pastry, beverages, and pet care. As of 2022, the company is currently led by Sidharta Prawira Oetama as its president director while Sanusi act as its president commissioner. Wikipedia
About Kino Indonesia Tbk PT
CEO-
Employees4.35K
FoundedFeb 8, 1999
Headquarters-
SectorPersonal care products
Websitekino.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.03T
1.03T
1.23T
1.26T
Cost of goods sold
570.50B
589.08B
716.92B
705.94B
Cost of revenue
570.50B
589.08B
716.92B
705.94B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
408.71B
393.64B
443.18B
462.86B
Operating expense
422.07B
389.40B
449.72B
469.44B
Total operating expenses
992.58B
978.49B
1.17T
1.18T
Operating income
40.06B
54.50B
61.94B
80.64B
Other non operating income
8.39B
11.25B
41.43B
8.01B
EBT including unusual items
14.06B
35.59B
71.23B
61.61B
EBT excluding unusual items
14.07B
35.56B
72.97B
61.61B
Income tax expense
-1.50B
13.36B
22.87B
-2.48B
Effective tax rate
-10.67%
37.52%
32.11%
-4.03%
Other operating expenses
-
-
5.03B
-
Net income
15.33B
21.31B
48.36B
63.01B
Net profit margin
1.48%
2.06%
3.94%
5.02%
Earnings per share
-
-
-
-
Interest and investment income
361.83M
363.60M
686.41M
629.61M
Interest expense
-32.40B
-34.19B
-30.58B
-27.37B
Net interest expenses
-32.04B
-33.83B
-29.89B
-26.75B
Depreciation and amortization charges
-
-
-
-
EBITDA
82.39B
98.39B
104.13B
123.22B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer